-
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Business - MarketWatch - October 30 -
Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales
Business - Financial Times - October 30 -
Here's why Eli Lilly bounced back, plus mega-caps lag while staples stocks rise
Business - CNBC - November 8 -
More than 2 dozen Big Lots stores no longer closing: Here's where
Politics - The Hill - November 12
More from CNBC
-
How tech bros bought 'America's most pro-crypto Congress ever'
Business - CNBC - 6 hours ago -
Data centers powering artificial intelligence could use more electricity than entire cities
Business - CNBC - 7 hours ago -
Donald Trump chooses hedge fund executive Scott Bessent for Treasury secretary
Business - CNBC - 20 hours ago -
Microsoft is finally testing its Recall photographic memory search feature. It's not perfect
Business - CNBC - 7 hours ago -
Activist Ananym has a list of suggestions for Henry Schein. How the firm can help improve profits
Business - CNBC - 7 hours ago